Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dna X (SONM) Other financing activities (2019 - 2024)

Dna X (SONM) has disclosed Other financing activities for 4 consecutive years, with $472000.0 as the latest value for Q2 2024.

  • For the quarter ending Q2 2024, Other financing activities rose 31.84% year-over-year to $472000.0, compared with a TTM value of $1.5 million through Jun 2024, down 25.55%, and an annual FY2023 reading of $1.5 million, down 3.55% over the prior year.
  • Other financing activities was $472000.0 for Q2 2024 at Dna X, up from $324000.0 in the prior quarter.
  • Across five years, Other financing activities topped out at $1.0 million in Q4 2022 and bottomed at $253000.0 in Q1 2022.
  • Average Other financing activities over 3 years is $430571.4, with a median of $324000.0 recorded in 2024.
  • Peak annual rise in Other financing activities hit 31.84% in 2024, while the deepest fall reached 4.85% in 2024.
  • Year by year, Other financing activities stood at $1.0 million in 2022, then plummeted by 65.48% to $358000.0 in 2023, then surged by 31.84% to $472000.0 in 2024.
  • Business Quant data shows Other financing activities for SONM at $472000.0 in Q2 2024, $324000.0 in Q1 2024, and $358000.0 in Q2 2023.